4 Weeks Treatment of Type II Diabetic Patients With BI 44847

NCT00558909 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: BI 44847
DRUG: placebo for BI 44847

Sponsor

Boehringer Ingelheim